Intra-abdominal aortic balloon occlusion in the management of placenta percreta

来源 :中华医学杂志英文版 | 被引量 : 0次 | 上传用户:Green__lucky
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background::Massive bleeding is the main concern for the management of placenta percreta (PP). Intra-abdominal aortic balloon occlusion (IABO) is one method for pelvic devascularization, but the efficacy of IABO is uncertain. This study aims to investigate the outcomes of IABO in PP patients.Methods::We retrospectively reviewed the clinical data of PP cases from six tertiary centers in China between January 2011 and December 2015. PP cases with/without the use of IABO were analyzed. Propensity score matching analysis was performed to reduce the effect of selection bias. Postpartum hemorrhage (PPH) and the rate of hysterectomy, as well as neonatal outcomes, were analyzed.Results::One hundred and thirty-two matched pairs of patients were included in the final analysis. Compared with the control group, maternal outcomes, including PPH (68.9% n vs. 87.9%, n χ2= 13.984, n P < 0.001), hysterectomy (8.3% n vs. 65.2%, n χ2= 91.672, n P < 0.001), and repeated surgery (1.5% n vs. 12.1%, n χ2 = 11.686, n P= 0.001) were significantly reduced in the IABO group. For neonatal outcomes, Apgar scores at 1 minute (8.67 ± 1.79 n vs. 8.53 ± 1.68, n t=-0.638, n P= 0.947) and 5 minutes (9.43 ± 1.55 n vs. 9.53 ± 1.26, n t = 0.566, n P = 0.293) were not significantly different between the two groups.n Conclusions::IABO can significantly reduce blood loss, hysterectomies, and repeated surgeries. This procedure has not shown harmful effects on neonatal outcomes.“,”Background::Massive bleeding is the main concern for the management of placenta percreta (PP). Intra-abdominal aortic balloon occlusion (IABO) is one method for pelvic devascularization, but the efficacy of IABO is uncertain. This study aims to investigate the outcomes of IABO in PP patients.Methods::We retrospectively reviewed the clinical data of PP cases from six tertiary centers in China between January 2011 and December 2015. PP cases with/without the use of IABO were analyzed. Propensity score matching analysis was performed to reduce the effect of selection bias. Postpartum hemorrhage (PPH) and the rate of hysterectomy, as well as neonatal outcomes, were analyzed.Results::One hundred and thirty-two matched pairs of patients were included in the final analysis. Compared with the control group, maternal outcomes, including PPH (68.9% n vs. 87.9%, n χ2= 13.984, n P < 0.001), hysterectomy (8.3% n vs. 65.2%, n χ2= 91.672, n P < 0.001), and repeated surgery (1.5% n vs. 12.1%, n χ2 = 11.686, n P= 0.001) were significantly reduced in the IABO group. For neonatal outcomes, Apgar scores at 1 minute (8.67 ± 1.79 n vs. 8.53 ± 1.68, n t=-0.638, n P= 0.947) and 5 minutes (9.43 ± 1.55 n vs. 9.53 ± 1.26, n t = 0.566, n P = 0.293) were not significantly different between the two groups.n Conclusions::IABO can significantly reduce blood loss, hysterectomies, and repeated surgeries. This procedure has not shown harmful effects on neonatal outcomes.
其他文献
目的:探讨外移股骨开髓点并设置个性化股骨外翻角能否改善合并股骨外弓的人工全膝关节置换术(total knee arthroplasty,TKA)患者下肢力线.方法:2016年3月至2018年10月,收治50例(55膝)合并股骨外弓拟行TKA的膝内翻畸形的骨关节炎患者.男10例,女40例;年龄63.1~80.5 (67.8±5.8)岁.单侧45例,双侧5例.55膝的骨关节炎分期均为Kellgren-Lawrence分级Ⅲ-Ⅳ级,病程2~10年.术前特种外科医院(Hospital for Special Su
目的:探讨应用经髌上入路交锁髓内钉技术治疗胫骨骨折的短期疗效.方法:2016年1月至2018年6月采用交锁髓内钉手术治疗80例胫骨骨折患者,根据手术入路不同分为观察组(经髌上入路)和对照组(经髌韧带入路).其中观察组40例,男28例,女12例,年龄28~67(46.70±10.34)岁;对照组40例,男30例,女10例,年龄31~69(49.38±10.74)岁.记录并比较分析两组患者手术时间,切口长度,术中X线机透视次数,术中失血量,骨折愈合时间,术后主动直腿抬高(straight leg raise,
目的:比较Endobutton带袢钛板与锁骨钩钢板治疗肩锁关节脱位的临床疗效及并发症.方法:回顾性2015年3月至2019年5月手术治疗的RockwoodⅢ-V型肩锁关节脱位患者48例,按照手术方法不同分为两组.其中23例采用Endobutton带袢钛板固定治疗(观察组),男15例,女8例;年龄23~59(36.2±8.1)岁;RockwoodⅢ型6例,Ⅳ型11例,V型6例.25例采用锁骨钩钢板治疗(对照组),男17例,女8例;年龄22~54(34.7±6.4)岁;Rock-woodⅢ型6例,Ⅳ型14例,
膝骨性关节炎相关的骨髓水肿样变(knee osteoarthritis-associated bone marrow edema-like lesions,KOA-BMLs)是一种常见的MRI影像学特征,主要表现为T2成像上软骨下骨的异常骨髓高信号.KOA-BMLs的形成可能与下肢力线以及软骨下骨灌注异常有关,而相关的组织病理学研究表明,这些损伤区域骨和骨髓的重建异常增加.在KOA患者中BMLs的大小可以在相对较短的时间内发生波动甚至消失,并且与疼痛、软骨下骨囊肿形成以及KOA病程进展密切相关.但是当前K
目的:探讨小干扰RNA (small interference RNA,siRNA) Piezo1沉默质粒转染骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)来源外泌体对骨关节炎(osteoarthritis,OA)动物模型的作用.方法:选取雄性SD大鼠SPF级20只,月龄5.46~6.96(6.21±0.75)个月,体重385.76~428.66(407.21±21.45)g,提取大鼠的BMSCs,利用siRNA技术构建Piezo1的siRNA沉默质粒
目的:探讨放射性n 125I粒子植入治疗头颈部恶性肿瘤的近期治疗效果。n 方法:本研究为回顾性研究,选取2014年9月至2019年3月北部战区总医院放射治疗科收治的29例接受放射性n 125I粒子植入治疗头颈部肿瘤复发的患者(共32个病灶),男24例,女5例,年龄(61.69±11.10)岁,年龄范围为41~82岁。在CT辅助下植入n 125I粒子,观察植入治疗后的治疗效果和不良反应情况。n 结果:125I粒子植入后2个月,局部有效率为53.1%(17/32)
期刊
目的:探讨传统增强CT及多模态影像[增强CT、正电子发射计算机体层显像仪(PET/CT)结合单光子发射计算机断层成像(SPECT)]引导下放射性n 125I粒子植入(RISI)对甲状腺癌肺转移瘤治疗的效果。n 方法:本研究为回顾性研究,选取2017年1月至2021年6月北部战区总医院核医学科收治的25例甲状腺癌术后肺转移瘤患者,男11例,女14例,年龄(53.1±13.4)岁,年龄范围为22~74岁。根据影像引导n 125I粒子植入治疗方式的不同,分为传统组(n n=
目的:观察n 18F-T807显像剂的安全性及其在阿尔茨海默病(AD)模型小鼠和正常老龄化小鼠体内的生物学分布。n 方法:选取无特定病原体级7月龄雄性昆明小鼠20只,体质量(22±2)g;10月龄雄性tau-转基因(appsw-tau,野生型/半合子)小鼠10只,体质量(34±2)g;10月龄雄性野生型C57BL/6J小鼠25只,体质量(28±2)g。将20只昆明小鼠采用随机数表法随机分成4组用于急性毒性实验,每组5只。对其中3组的小鼠分别尾静脉注射由1 ml生理盐水稀释的3.7 MBq
期刊